Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Australian Scientist wins “America’s Nobels”
By Karen Loudon / September 10, 2019
Congratulations to Cartherics' Scientific Advisor Jacques Miller. He co-shares the 2019 Lasker Award for medical research. Australian scientist, Professor Jacques...
Read More
Trials in Immune-Oncology
By Karen Loudon / September 6, 2019
The expansion of immunotherapies is a key trend to watch in cancer research 28 August, Sophie Laurenson, PhD https://www.clinicallabmanager.com Immunotherapy...
Read More
The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy
By Karen Loudon / September 5, 2019
CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive...
Read More
